The Pezcoller Foundation–AACR Scholar-in-Training grants

The AACR-Pezcoller Foundation Scholar-in-Training grants continue the AACR’s long-standing support of the next generation of cancer researchers, aimed:

  • to enhance participation in the programs and activities of the AACR by early-career investigators residing in Europe
  • to provide these outstanding Scholar-in-Training Awardees with an opportunity to share their research findings with the international cancer research community at the AACR Annual Meeting.

The Scholar-in-Training grants are highly competitive and recognize outstanding young investigators presenting meritorious papers at the AACR Annual Meeting’ poster exhibition.

 

ELIGIBILITY

  • Applicants must be the first author and presenter of an abstract submitted for presentation at the Annual Meeting.
  • Applicants must be an associate member of the AACR in good standing Nonmember graduate students, medical students and residents, clinical fellows or equivalent, and postdoctoral fellows who wish to apply for a Scholar-in-Training Award should first submit a membership application.

SELECTION

Successful applicants will be selected based on the merit of their abstract, CV, and personal statement; every effort will be made to notify awardees by the end of January.

Generally 5/6 of such fellowships are annually supported by the Pezcoller Foundation, to scientists in training who are travelling from Italy and Europe.
Those who may be interested to apply, or have any questions related to Scholar-in-Training Awards for the Annual Meeting, please email sita@aacr.org or visit Scholar-in-Training Awards.

The winners of the 2026 Scholar In Training; the President of the Pezcoller Foundation and the winners of the 2026 Pezcoller-AACR Award

Winners of the 2026 Pezcoller Scholar-In-Training

Charles H. Earnshaw (Cancer Research UK Manchester Institute, Manchester, United Kingdom) Glucocorticoids inhibit the GARP/TGF-βaxis initiating immune-dependent melanoma control

Maria Hønholt (Aarhus University, Aarhus, Denmark) Detection of postoperative minimal residual disease in colorectal cancer using a novel ultrasensitive whole-genome sequencing-based ctDNA test

Deborah Lenoci (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) Characterization of the intratumoral microbiota in non endemic EBV associated nasopharyngeal carcinoma

Armando Giuseppe Licata (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) Host-microbe-epigenetic crosstalk: Dissecting the role of microbiome, immune dysregulation, and DNA methylation in squamous cell carcinoma

Vincenzo Davide Pantina (University of Palermo,Palermo, Sicily, Italy) “Genetic background shapes mitochondrial metabolic adaptations underlying thyroid cancer progression”